Cardiology · Rare-to-common · teaser

ATTR cardiomyopathy

Updated August 2026 · TTR (wild-type + hereditary)

Teaser case. Selected price and peak-sales fields are held for a paid Brief — the rest is the method.

Influencer map

Weighted by trial leadership, guideline voice and advocacy reach — not follower count.

  • Mathew Maurer

    ATTR-CM trialist · Columbia

    US

    Staging · Trials · Imaging

  • Julian Gillmore

    NAC London · Royal Free / UCL

    UK

    NAC staging · Natural history

  • Marianna Fontana

    CMR · UCL

    UK

    Imaging · Regression

  • Martha Grogan

    Mayo ATTR · Mayo Clinic

    US

    Clinic network · wtATTR

  • Pablo Garcia-Pavia

    EU cardio · Puerta de Hierro

    ES

    Guidelines · vATTR

Centres & networks

Where the patients already are. Trial-active sites first.

  • Mayo Clinic ATTR

    Rochester, US · US amyloidosis centres

    Trial
  • Columbia / CUMC

    New York, US · US amyloidosis centres

    Trial
  • National Amyloidosis Centre

    London, UK · NHS NAC

    European referral core

    Trial
  • Puerta de Hierro

    Madrid, ES · EU amyloid network

    Trial
  • Kumamoto University

    Kumamoto, JP · vATTR endemic

    Trial

Voice

Thematic synthesis from advocacy, open caregiver forums, X, and clinician social. Directional — not a consented panel. We do not scrape closed groups.

CliniciansHigh

PYP changed the waiting room

We used to diagnose at autopsy. Now a scan on Friday fills Monday's clinic.

Diagnostic push is still the cheapest way to grow any ATTR franchise.

PatientsHigh

Price as a moral fact

A pill that costs a house, for a disease my father also has.

LoE in 2028 will be celebrated in patient groups. Brand loyalty is thin.

KOL socialRising

Stabilize vs silence vs edit

The argument on X is already about one-and-done, not about 6MWT deltas.

Editors set the terminal value of every chronic ATTR asset.